4baseCare, an Illumina Accelerator Company, that offers cutting-edge precision oncology solutions using advanced genomics and digital health technology, has launched operations in Dubai by establishing a state-of-the-art genomics lab at Dubai Science Park, in collaboration with Innovate Life Sciences. 

This expansion is in line with 4baseCare’s strategic plan to strengthen its footprint across Southeast Asia and the Middle East. The recent $6 million fund raise from Yali Capital has played a pivotal role in fueling this growth and paving the way for further expansion across other international geographies. 

4baseCare’s new genomics lab will provide cutting-edge genomic testing solutions, including comprehensive cancer gene panels, whole exome sequencing, and transcriptome analysis. These advanced tools will enable oncologists to delve deeper into the genetic makeup of tumours, offering personalised and more effective treatment options. 

India-based startup 4baseCare also unveiled SoLiq- A solid-liquid NGS tests portfolio that combines the best of both worlds—solid and liquid biopsy technologies—to give oncologists a 360° view of tumour biology.

Image caption- L to R- Iqbal Khan, CEO of Fajr Capital; Hitesh Goswami, CEO 4baseCare; Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park; Sudharshan Elangovan, VP Global Lab Operations & Regulations Affairs